ASHPOfficial

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the 2022 Midyear Clinical Meeting, our content matter experts will discuss key considerations regarding the prescription of OPAT or COpAT in the persons who inject drugs (PWID) population. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, speakers from the 2022 Midyear Clinical Meeting review the state of the Pharmacy Technician Workforce based on data from the 2022 ASHP National Survey. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will highlight a recently enacted North Dakota law requiring health plans to cover comprehensive medication management services provided by clinical pharmacists. The legislation, developed in collaboration with and supported by ASHP, will increase patients’ access to team-based services, better enabling pharmacists and clinicians to collaboratively optimize medication use and improve outcomes. Building on the success of the North Dakota bill, ASHP has drafted model legislation that other states can adopt to ensure patients have access to CMM services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Interested in ASHP policy but don’t know where to start? Heard of the House of Delegates but unsure of what it is or how to get there? Please join host Elyse MacDonald as she chats with the House of Delegates Chair, Melanie Dodd, as well as Delegates Mindy Burnworth and Brittany Tschaen, for a discussion of the House, ASHP policy, and how you can get involved!) The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Two experts in pain management in patients with Sickle Cell Disease (SCD) will discuss the causes of pain in patients with SCD as well the best practices in approaches to managing pain from pediatric patients and as they transition into adulthood. Challenges in pain management for patients with SCD will also be discussed including some strategies to overcome these challenges. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will discuss pain management and opioid safety programs for veterans, focusing on decreasing disparities in access to care and reducing stigma. Dr. Paige Mathew will share her work partnering with patients with chronic pain and lessons learned that you can apply to your practice for opioid use disorder treatment. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Throughout the month of June, we are sharing the voices of our members in the form of advice they might give to their younger selves. Join us this Pride Month for a daily series of reflections to inspire, reaffirm and support pharmacy professionals at all stages of their career journeys. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Radio frequency identification (RFID) technology is utilized in health systems throughout the medication use process, primarily for inventory management and revenue capture. In this episode, health-system pharmacy leaders delve into the results of previous research and explore the potential impact of RFID on patient and medication safety. This ASHP Foundation podcast is part of an initiative supported by Fresenius Kabi. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Whether you are a first-year student exploring post-graduate opportunities or a fourth-year student trying to decide what is next, learn more about what it is like to be a PGY1 pharmacy resident. This podcast will cover the day-to-day of a pharmacy resident and what opportunities you can pursue during each stage of your pharmacy school training to prepare for a residency. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Faculty from our Midyear Clinical Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this series, our content matter experts will present and discuss patient cases and management of vaccine preventable diseases. In this episode Norm Fenn reviews a patient. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode featuring content from the 2022 Midyear Clinical Meeting, content matter experts discuss the developing trends in the Medicaid reimbursement of the 340 B Program and available resources. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.